Summary

通过碳纳米粒子辅助甲状旁腺切除术 产生 甲状旁腺功能减退大鼠

Published: July 14, 2023
doi:

Summary

获得性甲状旁腺功能减退症(HypoPT)的动物模型对于了解HypoPT如何影响矿物离子稳态和验证新疗法的有效性至关重要。本文提出了一种使用碳纳米颗粒通过甲状旁腺切除术(PTX)生成获得性甲状旁腺功能减退症(AHypoPT)大鼠模型的技术。

Abstract

甲状旁腺功能减退症(HypoPT)是一种涉及甲状旁腺的罕见疾病,其特征是甲状旁腺激素(PTH)的分泌或效力减少,从而导致高血清磷水平和低血清钙水平。HypoPT 最常见的原因是甲状腺或其他颈部前部手术期间腺体意外损伤或切除。近年来,甲状旁腺/甲状腺手术变得越来越普遍,作为术后并发症的HypoPT的发生率相应增加。迫切需要一个HypoPT动物模型来更好地了解HypoPT对矿物离子稳态影响的机制,并验证新疗法的治疗效果。据报道,一种通过使用碳纳米颗粒进行甲状旁腺切除术(PTX)在雄性大鼠中产生获得性HypoPT的技术。与甲状旁腺功能减退症的小鼠模型相比,大鼠模型显示出很大的前景。重要的是,人PTH受体结合区与大鼠的序列相似度为84.2%,高于小鼠共有的73.7%相似度。此外,雌激素的影响可以影响PTH/PTHrP受体信号通路,尚未在雄性大鼠中得到充分研究。碳纳米颗粒是淋巴示踪剂,可将甲状腺淋巴结染成黑色而不影响其功能,但它们不会染色甲状旁腺,这使得它们易于识别和去除。在这项研究中,PTX后血清PTH水平检测不到,这导致了严重的低钙血症和高磷血症。因此,术后HypoPT的临床状态可以在大鼠模型中得到显着表现。因此,碳纳米颗粒辅助PTX可以作为研究HypoPT的发病机制,治疗和预后非常有效且易于实施的模型。

Introduction

甲状旁腺激素(PTH)由甲状旁腺分泌。它是钙平衡的主要调节剂,维持磷酸盐代谢,并参与骨转换12。甲状旁腺功能减退症 (HypoPT) 表现为 PTH 分泌减少或功能丧失。它是一种罕见的内分泌疾病,患病率约为 9-37/100,000 人年345。低PT的特征是血清PTH和钙水平降低,伴血清磷67升高。HypoPT根据其原因进行分类:获得性甲状旁腺功能减退症(AHypoPT)或特发性甲状旁腺功能减退症(IHypoPT)8。AHypoPT在临床实践中更常见;大约75%的AHypoPT病例是由甲状腺手术或其他头颈部手术期间甲状旁腺切除或意外损伤引起的。其他原因包括头颈部肿瘤的放化疗和药物毒性18。升级的诊断方法和甲状腺相关疾病筛查的增加增加了甲状腺外科手术的数量。这导致相关的甲状旁腺并发症相应增加910

需要易于建立的具有稳定特征的动物模型来更好地研究AHypoPT并验证新疗法的治疗效果。在以前的研究中已经报道了对大鼠和小鼠进行的甲状旁腺切除术(PTX)611;然而,由于甲状旁腺的尺寸极小,其解剖分布的可变性,在实践中成功率相对较低。因此,通常进行甲状腺-甲状旁腺切除术(TPTX)(即完全切除甲状腺和甲状旁腺)以确保切除甲状旁腺12。然而,由此产生的低甲状腺素水平可能会使该动物模型的研究复杂化13。通过其他方法(如药物刺激和基因编辑)建立的HypoPT模型不能正确代表最常见的AHypoPT发病机制。我们小组以前使用敲除小鼠模型来标记甲状旁腺,并允许在不损害甲状腺和周围解剖结构的情况下切除甲状旁腺1415。然而,该方法利用转基因小鼠模型,由于交配和育种要求,需要更长的开发时间。

因此,我们旨在建立一个易于生成的AHypoPT模型。本研究描述了使用碳纳米颗粒标记的PTX大鼠模型。甲状腺手术中常用的50mg/mL碳纳米颗粒悬浮液在局部注射后均匀分布在甲状腺中16。甲状腺变黑,但甲状旁腺未染色17,从而清楚地区分甲状旁腺和甲状腺,并允许在不影响甲状腺的情况下进行PTX。该方法适用于不同年龄的大鼠。碳纳米颗粒悬浮液的注射是安全的,对甲状腺功能的影响可以忽略不计18。本研究产生的碳纳米颗粒标记的PTX大鼠模型在4周观察期内显示出显着的低钙血症和高磷血症表型。因此,该AHypoPT模型易于建立,并且具有可重复的表型。

Protocol

本研究获得四川大学口腔疾病国家重点实验室机构动物护理与使用委员会的批准。在实验之前获得了当地相关机构的许可。本研究使用了八只8-10周龄的雄性Sprague-Dawley(SD)大鼠,平均体重为200-250g。这些动物是从商业来源获得的(见 材料表)。 在整个实验 期间随意提供食物和水。 1.产生碳纳米颗粒辅助PTX大鼠的术前准备 使用2.0%-2.5%?…

Representative Results

最初在解剖显微镜下在大鼠中观察到甲状旁腺的位置和数量。在碳纳米颗粒注射之前,甲状腺呈半透明的红色,在显微镜下几乎无法区分甲状旁腺(图1A)。纳米颗粒注射后,甲状腺被染成黑色,而甲状旁腺保持未染色(图1B)。仔细解剖浅色甲状旁腺,使甲状腺未受影响(图1C)。通常,甲状旁腺分布在甲状腺的外侧或后缘。…

Discussion

流行病学报告表明,甲状腺疾病的检测显着增加,进行的相关手术数量相应增加1920。术后甲状旁腺功能减退症的发病率约为7.6%821而获得性甲状旁腺功能减退症发病率的增加使这种罕见疾病受到更多的研究关注。因此,建立合适的动物模型来研究疾病的发病机制以及测试新疗法的结果尤为重要。但是,?…

Disclosures

The authors have nothing to disclose.

Acknowledgements

这项工作得到了国家自然科学基金基金81800928、四川大学华西学院/口腔医院的研究资助(RCDWJS2021-1)和口腔疾病国家重点实验室开放基金SKLOD-R013的支持。

Materials

0.9% Sodium Chloride Solution Kelun Co. Sichuan, China
10 µL 30G NanoFil Syringe WPI
6-0 polyglactin 910 suture with needle Ethicon, Inc J510G
Calcium LiquiColor test EKF 0155-225 For Ca2+ analysis
Carbon Nanoparticles Suspension Injection Lummy, Chongqing, China H20073246 1 mL : 50 mg
Creatinine (Cr) Assay kit ( sarcosine oxidase ) Jiancheng, Nanjing, China C011-2-1 For creatinine analysis
Disposable Scalpel Shinva, China
Dumstar Biology forceps Shinva, China
Micro Dissecting Spring Scissors Shinva, China
MicroVue Rat intact PTH ELISA Immunotopics 30-2531 For the measurement of PTH in rat serum
Needle Holder Shinva, China
Phosphorus Liqui-UV test EKF 0830-125 For Pi analysis
Ply gauze Weian Co. Henan, China
Povidone-Iodine Yongan pharmaceutical Co.Ltd. Chengdu, China
Prism 9.0 (statistics and graphing software) GraphPad Software, Inc., San Diego, CA, USA https://www.graphpad.com/scientific-software/prism/
Rat C-telopeptide of type I collagen (CTX-I) ELISA Kit CUSABIO, Wuhan, China CSB-E12776r For CTX-I analysis
Rat Osteocalcin/Bone Gla Protein (OT/BGP) ELISA Kit CUSABIO, Wuhan, China CSB-E05129r For osteocalcin analysis
Safety Single Edge Razor Blades American Safety Razor Company 66-0089
Sprague-Dawley Rats 8 to 10 weeks old
Surgical Incise Drapes Liangyou Co. Sichuan, China
Urea Assay Kit Jiancheng, Nanjing, China C013-2-1 For urea analysis

References

  1. Bilezikian, J. P., et al. Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. Journal of Bone and Mineral Research. 26 (10), 2317-2337 (2011).
  2. Bilezikian, J. P. Hypoparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 105 (6), 1722-1736 (2020).
  3. Underbjerg, L., Sikjaer, T., Mosekilde, L., Rejnmark, L. Postsurgical hypoparathyroidism-Risk of fractures, psychiatric diseases, cancer, cataract, and infections. Journal of Bone and Mineral Research. 29 (11), 2504-2510 (2014).
  4. Underbjerg, L., Sikjaer, T., Mosekilde, L., Rejnmark, L. The epidemiology of nonsurgical hypoparathyroidism in Denmark: A nationwide case finding study. Journal of Bone and Mineral Research. 30 (9), 1738-1744 (2015).
  5. Astor, M. C., et al. Epidemiology and health-related quality of life in hypoparathyroidism in Norway. The Journal of Clinical Endocrinology and Metabolism. 101 (8), 3045-3053 (2016).
  6. Rodriguez-Ortiz, M. E., et al. Calcium deficiency reduces circulating levels of FGF23. Journal of the American Society of Nephrology. 23 (7), 1190-1197 (2012).
  7. Davies, B. M., Gordon, A. H., Mussett, M. V. A plasma calcium assay for parathyroid hormone, using parathyroidectomized rats. The Journal of Physiology. 125 (2), 383-395 (1954).
  8. Clarke, B. L., et al. Epidemiology and diagnosis of hypoparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 101 (6), 2284-2299 (2016).
  9. Liu, Y., Shan, Z. Expert consensus on diagnosis and treatment for elderly with thyroid diseases in China. Aging Medicine. 4 (2), 70-92 (2021).
  10. Sulejmanovic, M., Cickusic, A. J., Salkic, S., Bousbija, F. M. Annual incidence of thyroid disease in patients who first time visit department for thyroid diseases in Tuzla Canton. Materia Socio-Medica. 31 (2), 130-134 (2019).
  11. Liao, H. W., et al. Relationship between fibroblast growth factor 23 and biochemical and bone histomorphometric alterations in a chronic kidney disease rat model undergoing parathyroidectomy. PloS One. 10 (7), 0133278 (2015).
  12. Russell, P. S., Gittes, R. F. Parathyroid transplants in rats: A comparison of their survival time with that of skin grafts. The Journal of Experimental Medicine. 109 (6), 571-588 (1959).
  13. Sakai, A., et al. Osteoclast development in immobilized bone is suppressed by parathyroidectomy in mice. Journal of Bone and Mineral Metabolism. 23 (1), 8-14 (2005).
  14. Bi, R., Fan, Y., Luo, E., Yuan, Q., Mannstadt, M. Two techniques to create hypoparathyroid mice: parathyroidectomy using GFP glands and diphtheria-toxin-mediated parathyroid ablation. Journal of Visualized Experiments. (121), e55010 (2017).
  15. Bi, R., et al. Diphtheria toxin- and GFP-based mouse models of acquired hypoparathyroidism and treatment with a long-acting parathyroid hormone analog. Journal of Bone and Mineral Research. 31 (5), 975-984 (2016).
  16. Huang, Y., et al. Carbon nanoparticles suspension injection for photothermal therapy of xenografted human thyroid carcinoma in vivo. MedComm. 1 (2), 202-210 (2020).
  17. Zhang, R. J., Chen, Y. L., Deng, X., Yang, H. Carbon nanoparticles for thyroidectomy and central lymph node dissection for thyroid cancer. The American Surgeon. , (2022).
  18. Long, M., et al. A carbon nanoparticle lymphatic tracer protected parathyroid glands during radical thyroidectomy for papillary thyroid non-microcarcinoma. Surgical Innovation. 24 (1), 29-34 (2017).
  19. Li, Y., et al. Efficacy and safety of long-term universal salt iodization on thyroid disorders: Epidemiological evidence from 31 provinces of mainland China. Thyroid. 30 (4), 568-579 (2020).
  20. Powers, J., Joy, K., Ruscio, A., Lagast, H. Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. Journal of Bone and Mineral Research. 28 (12), 2570-2576 (2013).
  21. Zihao, N., et al. Promotion of allogeneic parathyroid cell transplantation in rats with hypoparathyroidism. Gland Surgery. 10 (12), 3403-3414 (2021).
  22. Goncu, B., et al. Xenotransplantation of microencapsulated parathyroid cells as a potential treatment for autoimmune-related hypoparathyroidism. Experimental and Clinical Transplantation. , (2021).
  23. Jung, S. Y., et al. Standardization of a physiologic hypoparathyroidism animal model. PLoS One. 11 (10), 0163911 (2016).
  24. Chen, W., Lv, Y., Xie, R., Xu, D., Yu, J. Application of lymphatic mapping to recognize and protect parathyroid in thyroid carcinoma surgery by using carbon nanoparticles. Journal of Clinical Otorhinolaryngology, Head, and Neck Surgery. 28 (24), 1918-1920 (1924).
check_url/kr/64611?article_type=t

Play Video

Cite This Article
Song, Y., Li, P., Lyu, P., Yu, Y., Chen, X., Cui, C., Bi, R., Fan, Y. Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy. J. Vis. Exp. (197), e64611, doi:10.3791/64611 (2023).

View Video